Sanofi Makes $202M Investment in Vax Facility

Sanofi, confident in the growth of its influenza vaccines, has committed to spending $202 million to build a new manufacturing facility at its Val-de-Reuil site in north-western France.

The new facility will allow Sanofi Pasteur, the vaccines global business unit of Sanofi, to expand its supply of influenza vaccine, VaxigripTetra, to up to 70 countries in six continents. Sanofi Pasteur remains the sole influenza vaccine producer in the country.

The new facility, which will be the only site of its kind in France, will be completed by 2021 and should begin producing vaccines by 2022.

Several drugmakers are joining the growing group of protestors who are distancing themselves from the Fox News Channel shows featuring Tucker Carlson and Jeanine Pirro after the hosts were accused of making bigoted statements.

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.